Locations:
Search IconSearch

Supportive Evidence Mounts for Use of Mobile Stroke Units

New article reviews time-to-treatment data and looks ahead to emerging outcomes and cost studies

650×450-Mobile-Stroke

The future of mobile stroke units (MSUs) is bright, argue three Cleveland Clinic stroke neurologists in an article in the February 2018 issue of Endovascular Today.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“The improvement to time to treatment [with MSUs] is now well established in multiple data sets from around the world,” write M. Shazam Hussain, MD; Ken Uchino, MD; and Andrew Russman, DO, all with Cleveland Clinic’s Cerebrovascular Center.

One of those data sets is from Cleveland Clinic, which in July 2014 deployed one of the very first MSUs in the U.S. and has since reported significant reductions in time to treatment for patients with acute ischemic stroke managed in the Cleveland Clinic MSU compared with those managed in traditional emergency department settings.

The team’s Endovascular Today piece briefly reviews those results and similar findings from the earliest published experience with MSUs, which came from programs in Germany.

“The MSU concept is gaining traction in the United States and around the world,” Drs. Hussain, Uchino and Russman note, “with at least 15 active programs and many others in development.”

The authors also touch on the growing use of CT angiography by MSUs and on MSUs’ increasing role for field triage of patients with emergent large vessel occlusions for intra-arterial revascularization therapy.

They conclude with a look at the emerging wave of initial clinical outcomes data for patients managed on MSUs and a consideration of the nuanced cost-effectiveness issues around MSUs. “The incorporation of telemedicine may further improve cost-effectiveness [of MSUs],” they write, “as one physician can cover many MSUs as well as other duties rather than being committed to travelling with the ambulance.”

Advertisement

The Endovascular Today article is available here.

Advertisement

Related Articles

red blood cells floating in a blood vessel
February 27, 2026/Neurosciences/Cerebrovascular
Factor XIa Inhibition Drives Down Recurrent Stroke Risk Without Rise in Bleeding

OCEANIC-STROKE results represent long-sought advance in secondary stroke prevention

two brightly colored brain scans side by side
February 25, 2026/Neurosciences/Epilepsy
MR Fingerprinting Shows Potential to Reshape FCD Detection and Epileptogenicity Mapping

Two studies from Cleveland Clinic may help advance the technology toward broader clinical use

MRI scan of the side of a human head
February 20, 2026/Neurosciences/Cerebrovascular
Susac Syndrome: Insights on Rare Endotheliopathy From Largest Single-Center Cohort to Date

Distinct MRI signature includes lesions beyond the corpus callosum, features predictive of vision and hearing loss

Symbolic photo illustration: stethoscope on a medical dictionary
Is ‘Atypical Parkinsonism’ a Useful Term?

An argument for clarifying the nomenclature

Dr. Jagan Pillai against a decorative background
February 16, 2026/Neurosciences/Podcast
Blood Tests For Alzheimer’s: Diagnostic Help Comes With New Questions Too (Podcast)

An expert talks through the benefits, limits and unresolved questions of an evolving technology

stylized human brain against DNA double helix background
February 13, 2026/Neurosciences/Brain Tumor
Neurologic Manifestations of PTEN Hamartoma Tumor Syndrome Get Their Due in First-Ever Guidelines

Recommendations on identifying and managing neurodevelopmental and related challenges

brain scan showing a large white-rimmed lesion in top left portion
February 11, 2026/Neurosciences/Brain Tumor
Novel Strategies to Enhance Chemotherapy in Advanced Glioblastoma

Phase 2 trials investigate sitagliptin and methimazole as adjuvant therapies

data strings on computer screen merged with illustration of a brain clot
LLM-Based Tool Shows High Accuracy in Flagging Contraindications to Stroke Thrombolysis

Aim is for use with clinician oversight to make screening safer and more efficient

Ad